文献速递肺栓塞与肺血管病

肺血管介入:在适应中创新,在分化中进步

[Pulmonary vascular interventions: innovating through adaptation and advancing through differentiation].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2025-01-01

肺血管介入技术凭借微创、精准的优势,已成为肺血管疾病治疗的重要突破。球囊肺动脉成形术、肺动脉支架植入术、肺动脉去神经术等技术显著改善了慢性血栓栓塞性肺动脉高压、肺动脉狭窄、动脉型肺动脉高压等疾病的预后。肺血管介入借鉴了冠脉介入技术,但需针对肺循环特殊性进行改良,未来需构建独立理论体系。

要点

  • 球囊肺动脉成形术、肺动脉支架植入术、肺动脉去神经术显著改善CTEPH、肺动脉狭窄、PAH预后
  • 肺血管介入需针对肺循环低压、壁薄、分支复杂等特点改良,以避免穿孔和血栓风险
  • 未来方向包括专用器械研发、多模态影像融合、人工智能辅助和分子介入治疗

核心结论

  • 肺血管介入技术凭借微创、精准优势,已成为肺血管疾病治疗的重要突破。
  • 未来需构建肺血管介入独立理论体系,推动其从「辅助手段」向「核心治疗」升级。

研究设计与样本

  • 本文为综述,检索范围未在原文中报告。

主要发现

  • 球囊肺动脉成形术、肺动脉支架植入术、肺动脉去神经术等技术显著改善了慢性血栓栓塞性肺动脉高压、肺动脉狭窄、动脉型肺动脉高压等疾病的预后。
  • 肺血管介入借鉴了冠脉介入的导丝操控、球囊扩张、支架植入等技术,但需针对肺循环低压、壁薄、分支复杂等特殊性进行改良,以避免穿孔和血栓风险。
  • 专用器械的研发及影像融合成像的应用提升了精准性与安全性。

临床怎么用

  • 肺血管介入可凭借微创、精准优势用于慢性血栓栓塞性肺动脉高压、肺动脉狭窄、动脉型肺动脉高压等疾病的治疗。
  • 操作时需针对肺循环低压、壁薄、分支复杂等特点改良技术,以降低穿孔和血栓风险。
  • 可借助专用器械及影像融合成像提升精准性与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pulmonary vascular intervention technology, with its minimally invasive and precise advantages, has been a groundbreaking advancement in the treatment of pulmonary vascular diseases. Techniques such as balloon pulmonary angioplasty (BPA), pulmonary artery stenting, and percutaneous pulmonary artery denervation (PADN) have significantly improved the prognoses for conditions such as chronic thromboembolic pulmonary hypertension (CTEPH), pulmonary artery stenosis, and pulmonary arterial hypertension (PAH). Although based on coronary intervention (PCI) techniques such as guidewire manipulation and balloon dilatation, pulmonary vascular interventions require specific modifications to address the unique characteristics of the pulmonary circulation, low pressure, thin-walled vessels, and complex branching, to mitigate risks of perforation and thrombosis. Future directions include the development of dedicated instruments, multi-modality imaging guidance, artificial intelligence-assisted procedures, and molecular interventional therapies. These innovations aim to establish an independent theoretical framework for pulmonary vascular interventions, facilitating their transition from "adjuvant therapies" to "core treatments" in clinical practice. 肺血管介入技术凭借微创、精准的优势,已成为当前肺血管疾病治疗的重要突破。球囊肺动脉成形术(BPA)、肺动脉支架植入术、肺动脉去神经术(PADN)等技术显著改善了慢性血栓栓塞性肺动脉高压(CTEPH)、肺动脉狭窄、动脉型肺动脉高压(PAH)等疾病的预后。肺血管介入借鉴了冠脉介入(PCI)的导丝操控、球囊扩张、支架植入等技术,但需针对肺循环低压、壁薄、分支复杂等特殊性进行改良,以避免穿孔和血栓风险。专用器械的研发及影像融合成像的应用提升了精准性与安全性。未来需构建肺血管介入的独立理论体系,推动其从“辅助手段”向“核心治疗”升级。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li J, Wan J. [Pulmonary vascular interventions: innovating through adaptation and advancing through differentiation]. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 40300864. doi:10.3760/cma.j.cn112147-20250315-00143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。